Invesaro

Stocks Health care PMHS

OTC · Health care

Polomar Health Services, Inc. (PMHS)

It posted a net loss of $9.5M. At June 30, 2026 it held $178.9K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Watch PMHS in 60 seconds
Price
$0.17
+13.33% on the day · September 25, 2026
52-week range $0.07 to $0.80
Market cap
$4.8M

What Polomar Health Services, Inc. does

Polomar Health Services, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker PMHS.

Revenue and profit by year

Revenue
FY23: $34.5K $34.5K FY23FY23: $41.8K $41.8K FY23FY24: $58.8K $58.8K FY24FY25: $648.2K $648.2K FY25
Net income
FY23: -$181.1K -$181.1K FY23FY23: -$588K -$588K FY23FY24: -$1.3M -$1.3M FY24FY25: -$10.7M -$10.7M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$648.2K-$10.6M-$10.7M-$0.39n/a
2024$58.8K-$1.3M-$1.3M-$0.05-$1.1M
2023$41.8K-$440.8K-$588K-$0.02n/a
2023$34.5K-$181.5K-$181.1K$0.00n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 24, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 25, 2025. Not a date the company has announced. See the report calendar

Where PMHS ranks in Health care

Revenue$648.2K
#662 of 742 in Health care · Bottom 11%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Polomar Health Services, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 23, 2026
  2. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 27,847% to $1.5M versus the same quarter last year; diluted EPS $0.00 versus -$0.02.
  3. July 30, 2026
  4. July 20, 2026
  5. July 17, 2026
  6. July 6, 2026
  7. June 15, 2026
  8. June 1, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue rose 22,038% to $1M versus the same quarter last year; diluted EPS $0.00 versus -$0.02.
  9. May 18, 2026
  10. May 15, 2026

Recent insider filings (Forms 3, 4 and 144): 8, the latest on September 17, 2025. Insider transactions on SEC

Insider trades

What the people running Polomar Health Services, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days

All insider filings on SEC.gov · Where insiders are buying across the market

All filings on SEC EDGAR

Questions about PMHS

What does Polomar Health Services, Inc. do?

Polomar Health Services, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on OTC under the ticker PMHS.

Is Polomar Health Services, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $9.5M.

When did Polomar Health Services, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the form POS AM filing from September 23, 2026.

Similar companies

Compare PMHS with

Compare PMHS with any company

Follow PMHS

Get an email when Polomar Health Services, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PMHS: get an email when it files

Where the numbers come from

Financial figures are the values Polomar Health Services, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.